MEDICAMENTE ANTINEOPLAZICE 1

TED · 768869-2026Award noticeawardedNo deadline given

Buyer

NameSPITALUL CLINIC C.F. CLUJ

CountryRO

Published2026-11-05

Deadline—

Value

Estimated€4,856,006 · 25,933,502.64 RON

Awarded€2,383,124 · 12,727,071.29 RON

See this firm's wins →

Who already wins at this buyer

Firms with recorded awards from SPITALUL CLINIC C.F. CLUJ in this tender’s CPV categories — the incumbents you are bidding against.

Firm	Wins	Awarded	Last win
ALLIANCE HEALTHCARE ROMANIA \| FRESENIUS KABI ROMANIA \| Kembli-Med \| ND PHARMA S.R.L. \| DONA. LOGISTICA \| DR.MAX \| CHIMIMPORTEXPORT PLURIMEX \| FELSIN FARM \| FARMEXIM S.A. \| Pharma \| BIOEEL	1	—	2026-07-14
ND PHARMA S.R.L. \| ALLIANCE HEALTHCARE ROMANIA \| DR.MAX \| FRESENIUS KABI ROMANIA \| B.BRAUN MEDICAL \| BIOEEL \| DONA. LOGISTICA \| FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L. \| FARMEXIM S.A. \| FELSIN FARM \| PHARM AHEAD S.R.L. \| Pharma \| Prisum Healthcare \| PHARMA VISION PLUS	1	—	2026-05-08
NOVENTIS International \| FRESENIUS KABI ROMANIA SRL \| ZENMED SOLUTIONS \| SANROTEX TRADING SRL \| BIZMED SRL \| Novaintermed S.R.L.	1	—	2026-09-09

Full buyer profile: what SPITALUL CLINIC C.F. CLUJ buys and who wins it →

CPV codes

33652100 Medical equipment & pharmaceuticals

Description

Medicamente antineoplazice 1. A se vedea Caietul de sarcini.Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificare/informatiilor suplimentare in a 12-a zi inainte de termenul limita stabilit pentru depunerea ofertelor, Nr zile pana la care se pot solicita clarificari inainte de data de depunere a ofertelor este 20

Source

View the official notice on TED ↗

Related parliamentary activity (suggestie)

Tweede Kamer documents (motions, questions, letters) that read as related to this — a semantic suggestion from motiefeed.nl, not an official link.

Beslisnota bij Kamerbrief over Stand van zaken toezeggingen eerstelijns apotheekzorg en geneesmiddelen · Bijlage · 2026-07-17 · 86%
Beslisnota bij Kamerbrief over Gezondheidsraadadvies 'Screening op HPA-1a- antistoffen tijdens de zwangerschap' · Bijlage · 2026-06-11 · 86%
Eerstelijnszorg · Brief regering · 2026-07-17 · 86%